The global spinal cord stimulation (SCS) devices market is experiencing significant growth as hospitals, pain management centers, neurology clinics, and specialty healthcare facilities increasingly invest in advanced implantable neuromodulation technologies. Rising incidence of chronic pain conditions, expanding awareness of non-opioid treatment options, improving reimbursement frameworks, and...